Public release date: 16-May-2012 [ | E-mail | Share ] <\/p>\n
Contact: Tom Rickey tom_rickey@urmc.rochester.edu<\/a> 585-275-7954 University of Rochester Medical Center<\/p>\n A well-known genetic risk factor for Alzheimer's disease triggers a cascade of signaling that ultimately results in leaky blood vessels in the brain, allowing toxic substances to pour into brain tissue in large amounts, scientists report May 16 in the journal Nature. <\/p>\n The results come from a team of scientists investigating why a gene called ApoE4 makes people more prone to developing Alzheimer's. People who carry two copies of the gene have roughly eight to 10 times the risk of getting Alzheimer's disease than people who do not. <\/p>\n A team of scientists from the University of Rochester, the University of Southern California, and other institutions found that ApoE4 works through cyclophilin A, a well-known bad actor in the cardiovascular system, causing inflammation in atherosclerosis and other conditions. The team found that cyclophilin A opens the gates to the brain assault seen in Alzheimer's. <\/p>\n \"We are beginning to understand much more about how ApoE4 may be contributing to Alzheimer's disease,\" said Robert Bell, Ph.D., the post-doctoral associate at Rochester who is first author of the paper. \"In the presence of ApoE4, increased cyclophilin A causes a breakdown of the cells lining the blood vessels in Alzheimer's disease in the same way it does in cardiovascular disease or abdominal aneurysm. This establishes a new vascular target to fight Alzheimer's disease.\" <\/p>\n The team found that ApoE4 makes it more likely that cyclophilin A will accumulate in large amounts in cells that help maintain the blood-brain barrier, a network of tightly bound cells that line the insides of blood vessels in the brain and carefully regulates what substances are allowed to enter and exit brain tissue. <\/p>\n ApoE4 creates a cascade of molecular signaling that weakens the barrier, causing blood vessels to become leaky. This makes it more likely that toxic substances will leak from the vessels into the brain, damaging cells like neurons and reducing blood flow dramatically by choking off blood vessels. <\/p>\n Doctors have long known that the changes in the brain seen in Alzheimer's patients the death of crucial brain cells called neurons begins happening years or even decades before symptoms appear. The steps described in Nature discuss events much earlier in the disease process. <\/p>\n The idea that vascular problems are at the heart of Alzheimer's disease is one championed for more than two decades by Berislav Zlokovic, M.D., Ph.D., the leader of the team and a neuroscientist formerly with the University of Rochester Medical Center and now at USC. For 20 years, Zlokovic has investigated how blood flow in the brain is affected in people with the disease, and how the blood-brain barrier allows nutrients to pass into the brain, and harmful substances to exit the brain. <\/p>\n<\/p>\n Originally posted here: Public release date: 16-May-2012 [ | E-mail | Share ] Contact: Tom Rickey tom_rickey@urmc.rochester.edu<\/a> 585-275-7954 University of Rochester Medical Center A well-known genetic risk factor for Alzheimer's disease triggers a cascade of signaling that ultimately results in leaky blood vessels in the brain, allowing toxic substances to pour into brain tissue in large amounts, scientists report May 16 in the journal Nature. Continue reading
\nAlzheimer's gene causes brain's blood vessels to leak, die<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"